PRESS RELEASES - 2002 Archive

11-19-2002
Wheat Ridge, Colorado
Bolder BioTechnology Awarded Grant From The National Cancer Institute To Develop Long-Acting Angiostatin Proteins For Treating Cancer
    >>Click here for complete News Release

12-11-2002
Wheat Ridge, Colorado
Bolder BioTechnology Receives Phase II SBIR Grant to Develop Long-Acting Cytokine Conjugates for Treating Thrombocytopenia
    >>Click here for complete News Release

Back to News